Related Experiment Videos
Nucleus pulposus allograft retards intervertebral disc degeneration
1Department of Orthopaedic Surgery, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Clinical Orthopaedics and Related Research
|August 15, 2001
Summary
Nucleus pulposus allografts, including intact tissue or cells, effectively slow intervertebral disc degeneration. Intact grafts were more beneficial than cell injections, with no significant immune rejection observed.
Area of Science:
- Regenerative Medicine
- Orthopedics
- Cell Biology
Background:
- Intervertebral disc degeneration is a significant cause of back pain.
- Autogenous grafts of nucleus pulposus (NP) or NP cells can slow degeneration but harm the donor site.
- The efficacy and immunogenicity of allogeneic NP grafts require investigation.
Purpose of the Study:
- To evaluate if nucleus pulposus allografts can retard induced intervertebral disc degeneration.
- To determine if these allografts elicit an immunologic rejection response.
Main Methods:
- Lumbar disc degeneration was induced in rabbits by nucleus pulposus aspiration.
- Intact NP allografts or NP cells were injected into degenerated discs.
- Histological and immunological analyses were performed over 16 weeks.
Main Results:
- Intact NP allografts significantly retarded disc degeneration, outperforming NP cell injections.
- Both graft types were superior to sham procedures and controls.
- No significant host-versus-graft immune response was detected.
Conclusions:
- Nucleus pulposus allografts, particularly intact tissue, are effective in mitigating intervertebral disc degeneration.
- Allogeneic NP transplantation is a viable strategy without inducing significant immune rejection.
- The extracellular matrix of the nucleus pulposus plays a crucial role in disc preservation.